Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Unaudited)

v3.8.0.1
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2018
Dec. 31, 2017
CURRENT ASSETS    
Cash and cash equivalents $ 4,022 $ 9,541
Accounts receivable, net of allowance for doubtful accounts of 2018 $7,003; 2017 $6,539 10,335 10,958
Assets held for sale 2,058 0
Other current assets 2,622 2,707
Total current assets 19,037 23,206
FIXED ASSETS, net of accumulated depreciation 4,876 5,550
OTHER ASSETS    
Restricted cash 350 350
Patents and other intangible assets, net of accumulated amortization 4,375 4,478
Investment in joint venture 244 246
Goodwill 17,257 17,992
Other 305 399
Total other assets 22,531 23,465
Total Assets 46,444 52,221
CURRENT LIABILITIES    
Accounts payable and accrued expenses 8,921 8,715
Obligations under capital leases, current portion 319 272
Liabilities held for sale 221 0
Deferred revenue 1,751 516
Line of credit 3,510 4,137
Term note, current portion 6,000 6,000
Total current liabilities 20,722 19,640
Obligations under capital leases 641 624
Deferred rent payable and other 324 360
Warrant liability 3,711 4,403
Deferred revenue, long-term 992 429
Total Liabilities 26,390 25,456
STOCKHOLDERS’ EQUITY    
Preferred stock, authorized 9,764 shares, $0.0001 par value, none issued 0 0
Common stock, authorized 100,000 shares, $0.0001 par value, 27,730 and 27,754 shares issued and outstanding at March 31, 2018 and December 31, 2017, respectively 3 3
Additional paid-in capital 161,801 161,527
Accumulated other comprehensive income 49 69
Accumulated (deficit) (141,799) (134,834)
Total Stockholders’ Equity 20,054 26,765
Total Liabilities and Stockholders’ Equity $ 46,444 $ 52,221